Research

Hormonal

DJB implantation significantly improves glycemic control (HbA1c reduction) in patients with Type 2 Diabetes Mellitus.

For patients with Type 2 Diabetes, the DJB device can lower HbA1c levels from an average of 5.6% to 5.1% after one year. This improvement in blood sugar control is a key benefit alongside weight loss.

ModerateSupportsMEDIUM confidence
The mean HbA1c after explantation was 5.1% (p = 0.0001).
Jan Král et al. · Obesity Surgery · 2023

Why this rating

Retrospective observational study, subset of patients (n=52 for HbA1c data).

Source

Long-term Results of Duodeno-jejunal Bypass in the Treatment of Obesity and Type 2 Diabetes

Jan Král et al. · Obesity Surgery · 2023

DOI 10.1007/s11695-023-06979-4

cohort · n=121Cited 3×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →